Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Clinical trial NCT02023021 · COMPLETED

Trial details

NCT number: NCT02023021
Sponsor: Xian-Jun Yu
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IA Pancreatic Adenocarcinoma Stage IB Pancreatic Adenocarcinoma Stage IIA Pancreatic Adenocarcinoma Stage IIB Pancreatic Adenocarcinoma

Start date: 2014-01-01
Primary completion: 2018-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.